Related Experiment Video
Updated: Jul 11, 2025

Rat Model of Right-Sided Cardiac Remodeling and Arrhythmia Using Pulmonary Artery Banding
Published on: August 30, 2024
Arrhythmic risk stratification in arrhythmogenic right ventricular cardiomyopathy
Alessio Gasperetti1,2,3, Cynthia A James1, Richard T Carrick1
1Division of Cardiology, Department of Medicine, Johns Hopkins University, Blalock 545, 600 N. Wolfe St., Baltimore, MD 21287, USA.
Insights
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a genetic heart condition causing sudden cardiac death. A new risk calculator aids in preventing arrhythmias and personalizing patient care.
Area of Science:
- Cardiology
- Genetics
- Medical Technology
Background:
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a heritable heart muscle disease.
- It is a primary cause of sudden cardiac death (SCD) in athletes.
- Current management focuses on SCD prevention via implantable cardioverter defibrillators (ICDs).
Purpose of the Study:
- To review the evidence supporting a novel ARVC risk stratification tool.
- To discuss the clinical implementation of a new risk calculator for ARVC patients.
Main Methods:
- Review of international ARVC research and clinical data.
- Validation of a novel risk calculator algorithm for predicting arrhythmias.
- Analysis of patient-centered risk stratification approaches.
Main Results:
- Significant advancements in individualized risk assessment for ARVC.
- A validated risk calculator now estimates 5-year arrhythmia risk in ARVC patients.
- The tool supports personalized, patient-centered care strategies.
Conclusions:
- The novel risk calculator represents a significant step in managing ARVC.
- Implementing this tool can optimize SCD prevention and patient care.
- Further integration into clinical practice is recommended for ARVC management.
Abstract:
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a heritable cardiomyopathy characterized by a predominantly arrhythmic presentation. It represents the leading cause of sudden cardiac death (SCD) among athletes and poses a significant morbidity threat in the general population. As a causative treatment for ARVC is still not available, the placement of an implantable cardioverter defibrillator represents the current cornerstone for SCD prevention in this setting. Thanks to international ARVC-dedicated efforts, significant steps have been achieved in recent years towards an individualized, patient-centred risk stratification approach. A novel risk calculator algorithm estimating the 5-year risk of arrhythmias of patients with ARVC has been introduced in clinical practice and subsequently validated. The purpose of this article is to summarize the body of evidence that has allowed the development of this tool and to discuss the best way to implement its use in the care of an individual patient.
More Related Videos
07:38Comprehensive Echocardiographic Assessment of Right Ventricle Function in a Rat Model of Pulmonary Arterial Hypertension
Published on: January 20, 2023
09:36Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia
Published on: December 22, 2023
Related Concept Videos
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
Dysrhythmias V: Evaluating Dysrhythmias
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Mechanism of Cardiac Arrhythmias